CD33 and acute myeloid leukemia: Flow cytometry immunophenotyping (Figure 2) from peripheral blood revealed increased circulating myeloid blasts (11.4% of cells), expressing CD34, CD117, HLA-DR, and subsets of CD33 and CD13, consistent with AML.